Partitioned Reagent Reservoir Helps Save Deck Space
Porvair Sciences has announced a new 4-row partitioned reservoir plate that enables aspiration of up to four reagents into a single well space thereby saving valuable deck space on your automated liquid handling system.
The new plate is partitioned into four rows with thin walls to allow pipette tips with strippers to easily reach the bottom of the channelled reservoir. Each row holds 73ml thereby providing a total volume of 292 ml.
The plates are designed for use with almost any automated liquid handling or pipetting system. The pyramid bottoms reduce reagent waste by providing a collection area with a dead volume of less than 0.5ml.
The new 4-row partitioned reservoirs are constructed in ultra-pure, chemically resistant virgin polypropylene to eliminate contamination of samples or reagents with extractables and leachates from the plate material. An optional polypropylene lid is available to minimise reagent evaporation and enable stacking of reservoir plates. The reservoirs are available in packs of 25.
For further information or a free sample plates please contact Porvair Sciences on telephone +44-1932-240255 or email int.sales@porvair-sciences.com.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Read moreHans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region